Leonard Gomella

Leonard Gomella

UNVERIFIED PROFILE

Are you Leonard Gomella?   Register this Author

Register author
Leonard Gomella

Leonard Gomella

Publications by authors named "Leonard Gomella"

Are you Leonard Gomella?   Register this Author

100Publications

2071Reads

35Profile Views

Evolution of the Liquid Biopsy in Metastatic Prostate Cancer.

Urology 2019 Oct 14;132:1-9. Epub 2019 Jun 14.

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.06.006DOI Listing
October 2019

Prostate Contrast Enhanced Transrectal Ultrasound Evaluation of the Prostate With Whole-Mount Prostatectomy Correlation.

Urology 2019 Aug 1. Epub 2019 Aug 1.

Department of Radiology, Thomas Jefferson University Hospital, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2019.07.026DOI Listing
August 2019

Mortality and Hospitalization Risk Following Oral Androgen Signaling Inhibitors Among Men with Advanced Prostate Cancer by Pre-existing Cardiovascular Comorbidities.

Eur Urol 2019 Aug 2. Epub 2019 Aug 2.

Department of Medical Oncology, Sidney Kimmel Cancer Center at Jefferson, Sidney Kimmel Medical College, Philadelphia, PA, USA; Sidney Kimmel Cancer Center at Jefferson, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S03022838193058
Publisher Site
http://dx.doi.org/10.1016/j.eururo.2019.07.031DOI Listing
August 2019

Viral Therapy for Bladder Cancer: Everything Old is New Again.

Can J Urol 2019 Aug;26(4):9802

Thomas Jefferson University/Philadelphia PA, USA.

View Article

Download full-text PDF

Source
August 2019

Prevalence of Suspected Hereditary Cancer Syndromes and Germline Mutations Among a Diverse Cohort of Probands Reporting a Family History of Prostate Cancer: Toward Informing Cascade Testing for Men.

Eur Urol Oncol 2019 Jul 2. Epub 2019 Jul 2.

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA; Cancer Risk Assessment and Clinical Cancer Genetics, Division of Population Science, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S25889311193008
Publisher Site
http://dx.doi.org/10.1016/j.euo.2019.06.010DOI Listing
July 2019

Germline Testing for Men With Prostate Cancer: Navigating an Expanding New World of Genetic Evaluation for Precision Therapy and Precision Management.

J Clin Oncol 2019 Jun 12;37(17):1455-1459. Epub 2019 Apr 12.

1 Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.18.02181DOI Listing
June 2019

Impact of Tumor Regional Involvement on Active Surveillance Outcomes: Validation of the Cumulative Cancer Location Metric in a US Population.

Eur Urol Focus 2019 May 18. Epub 2019 May 18.

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia PA, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.euf.2019.05.001DOI Listing
May 2019

Is BCG a Hazardous Drug? Ask NIOSH, OSHA, and the USP.

Can J Urol 2019 Apr;26(2):9687-9689

Thomas Jefferson University / Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
April 2019

Overlapping surgeries: defining the 'critical portions' of the procedure.

Can J Urol 2019 Apr;26(2):9694-9698

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
April 2019

Before Ordering a Genetic Test Get to Know GINA.

Can J Urol 2018 12;25(6):9569

FACS, Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
December 2018

Nuclear Pores Promote Lethal Prostate Cancer by Increasing POM121-Driven E2F1, MYC, and AR Nuclear Import.

Cell 2018 08 9;174(5):1200-1215.e20. Epub 2018 Aug 9.

Cancer Biology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Medical Oncology Department, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA; Pathology Department, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cell.2018.07.015DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6150493PMC
August 2018

Should Urology Reconsider the Routine Use of Fluoroquinolones?

Can J Urol 2018 08;25(4):9366

Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
August 2018

VPAC1-targeted PET/CT scan: improved molecular imaging for the diagnosis of prostate cancer using a novel cell surface antigen.

World J Urol 2018 May 14;36(5):719-726. Epub 2018 Mar 14.

Department of Urology, Sidney Kimmel Medical College at Thomas Jefferson University, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, 1025 Walnut St, Suite 1102, Philadelphia, PA, 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00345-018-2263-1DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6487499PMC
May 2018

Multidisciplinary Clinical Treatment of Head and Neck Cancer.

JAMA Otolaryngol Head Neck Surg 2018 05;144(5):460-461

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jamaoto.2017.3437DOI Listing
May 2018

Prostate Cancer CRPC Stage M0 and M1: Do We Need Stage M0.5?

Can J Urol 2018 04;25(2):9220

Thomas Jefferson University, Philadelphia, PA USA.

View Article

Download full-text PDF

Source
April 2018

Role of Genetic Testing for Inherited Prostate Cancer Risk: Philadelphia Prostate Cancer Consensus Conference 2017.

J Clin Oncol 2018 02 13;36(4):414-424. Epub 2017 Dec 13.

Veda N. Giri, Karen E. Knudsen, William K. Kelly, Robert B. Den, Adam P. Dicker, Jean Hoffman-Censits, Mark D. Hurwitz, Colette Hyatt, Grace Lu-Yao, Mark J. Mann, James R. Mark, Peter A. McCue, Ronald E. Myers, Stephen C. Peiper, Edouard J. Trabulsi, and Leonard G. Gomella, Jefferson Sidney Kimmel Cancer Center; Justin E. Bekelman, University of Pennsylvania Perelman School of Medicine; S. Bruce Malkowicz, University of Pennsylvania; Elias Obeid and Robert Uzzo, Fox Chase Cancer Center; Gordon F. Schwartz, Foundation for Breast and Prostate Health, Philadelphia; Mark S. Shahin, Hanjani Institute for Gynecologic Oncology, Abington Hospital-Jefferson Health, Abington, PA; Wassim Abida, Philip Kantoff, and Mark E. Robson, Memorial Sloan Kettering Cancer Center; Mitchell C. Benson, Columbia University, New York, NY; Gerald L. Andriole, Washington University School of Medicine, St Louis, MO; Chris H. Bangma, Erasmus Medical Center, Rotterdam, the Netherlands; Amie Blanco, and Matthew Cooperberg, University of California, San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco; Christopher J. Kane, University of California San Diego, San Diego; Howard Sandler, Cedars-Sinai Medical Center, Los Angeles; Howard R. Soule, Prostate Cancer Foundation, Santa Monica, CA; Arthur Burnett, William B. Isaacs, Christian P. Pavlovich, and Patrick C. Walsh, Johns Hopkins Medical Institutions, Baltimore; Peter A. Pinto and Carol J. Weil, National Cancer Institute, Bethesda, MD; William J. Catalona and Edward Schaeffer, Northwestern University Feinberg School of Medicine; Scott Eggener, Sarah M. Nielsen, and Donald J. Vander Griend, University of Chicago, Chicago, IL; Kathleen A. Cooney, University of Utah School of Medicine, Salt Lake City, UT; David E. Crawford, University of Colorado, Aurora; Lawrence I. Karsh, The Urology Center of Colorado, Denver; Wendy Poage, Prostate Conditions Education Council, Elizabeth, CO; Neil Fleshner, University of Toronto Princess Margaret Cancer Centre, Toronto, Ontario, Canada; Matthew L. Freedman, Kevin R. Loughlin, and Timothy R. Rebbeck, Dana Farber Cancer Institute, and Harvard TH Chan School of Public Health, Boston, MA; Freddie C. Hamdy, University of Oxford, Oxford, England; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; Eric A. Klein, Cleveland Clinic, Cleveland; Robert Pilarski, The Ohio State University, Columbus, OH; Daniel W. Lin, University of Washington, Seattle, WA; Martin M. Miner, Brown University, Providence, RI; Todd Morgan and Scott A. Tomlins, University of Michigan, Ann Arbor; Matt T. Rosenberg, Mid-Michigan Health Center, Jackson, MI; Judd W. Moul, Duke University, Duke Cancer Institute, Durham, NC; David F. Penson, Vanderbilt University Medical Center, Nashville, TN; Daniel Petrylak and Brian Shuch, Yale University, New Haven, CT; Curtis A. Pettaway, The University of Texas MD Anderson Cancer Center, Houston; Ganesh V. Raj, University of Texas Southwestern Medical Center at Dallas, Dallas, TX; Oliver Sartor, Tulane University Medical School, New Orleans, LA; Neal D. Shore, Atlantic Urology Clinics/Carolina Urologic Research Center, Myrtle Beach, SC; and Richard Wender, American Cancer Society, Atlanta, GA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.74.1173DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6075860PMC
February 2018

The perlecan-interacting growth factor progranulin regulates ubiquitination, sorting, and lysosomal degradation of sortilin.

Matrix Biol 2017 12 20;64:27-39. Epub 2017 Apr 20.

Department of Urology, Biology of Prostate Cancer Program, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S0945053X173010
Publisher Site
http://dx.doi.org/10.1016/j.matbio.2017.04.001DOI Listing
December 2017

New Urologic Oncology Drugs and The New Toxicities.

Can J Urol 2017 12;24(6):9075

Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
December 2017

Intravesical rAd-IFNα/Syn3 for Patients With High-Grade, Bacillus Calmette-Guerin-Refractory or Relapsed Non-Muscle-Invasive Bladder Cancer: A Phase II Randomized Study.

J Clin Oncol 2017 Oct 23;35(30):3410-3416. Epub 2017 Aug 23.

Neal D. Shore, Carolina Urologic Research Center, Myrtle Beach, SC; Stephen A. Boorjian, Mayo Clinic, Rochester, MN; Daniel J. Canter, Ochsner Health System, New Orleans, LA; Kenneth Ogan, Emory University, Atlanta, GA; Lawrence I. Karsh, The Urology Center of Colorado, Denver, CO; Tracy M. Downs, University of Wisconsin, Madison, WI; Leonard G. Gomella, Thomas Jefferson University, Philadelphia, PA; Ashish M. Kamat and Colin P.N. Dinney, University of Texas MD Anderson Cancer Center; Seth P. Lerner, Baylor College of Medicine, Houston; Yair Lotan, University of Texas Southwestern Medical Center, Dallas; Robert S. Svatek, University of Texas Health Science Center at San Antonio, San Antonio, TX; Trinity J. Bivalacqua, Johns Hopkins School of Medicine, Baltimore, MD; Robert L. Grubb III, Washington University, St Louis, MO; Tracey L. Krupski, University of Virginia, Charlottesville, VA; Michael E. Woods and Matthew I. Milowsky, University of North Carolina, Chapel Hill; Brant A. Inman, Duke University, Durham, NC; Alan Boyd, Alan Boyd Consultants, Cottenham; F. Peter Treasure, Peter Treasure Statistical Services, King's Lynn, United Kingdom; Gillian Gregory, David G. Sawutz, and Nigel R. Parker, FKD Therapies Oy; and Seppo Yla-Herttuala, A.I. Virtanen Institute University of Eastern Finland and Science Service Center and Gene Therapy Unit, Kuopio, Finland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2017.72.3064DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5648171PMC
October 2017

Where have all the sperm gone?

Can J Urol 2017 10;24(5):8972

Thomas Jefferson University,Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
October 2017

Hematologic Toxicity of Concurrent Administration of Radium-223 and Next-generation Antiandrogen Therapies.

Am J Clin Oncol 2017 Aug;40(4):342-347

Departments of *Radiation Oncology †Medical Oncology ‡Urology, Kimmel Cancer Center, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0000000000000181DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4549230PMC
August 2017

VPAC1 Targeted Cu-TP3805 kit preparation and its evaluation.

Nucl Med Biol 2017 Aug 3;51:55-61. Epub 2017 May 3.

Thomas Jefferson University, Department of Radiology; The Sidney Kimmel Cancer Center. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S09698051173007
Publisher Site
http://dx.doi.org/10.1016/j.nucmedbio.2017.04.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5507078PMC
August 2017

Development of a voided urine assay for detecting prostate cancer non-invasively: a pilot study.

BJU Int 2017 06 16;119(6):885-895. Epub 2017 Feb 16.

Department of Radiology, Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/bju.13775DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444967PMC
June 2017

Prevalence and Characteristics of Patients with Suspected Inherited Renal Cell Cancer: Application of the ACMG/NSGC Genetic Referral Guidelines to Patient Cohorts.

J Genet Couns 2017 Jun 19;26(3):548-555. Epub 2017 Jan 19.

Cancer Risk Assessment and Clinical Cancer Genetics Program, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10897-016-0020-4DOI Listing
June 2017

Nonpalpable Intratesticular Mass in a Young Man With a History of Contralateral Retractile Testis.

Oncology (Williston Park) 2017 06;31(6):484, 489-91

View Article

Download full-text PDF

Source
June 2017

The Urology Guide to Coffee and Tea.

Can J Urol 2017 Jun;24(3):8782-8783

Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
June 2017

The Liquid Biopsy for Prostate Cancer 25 Years Later.

Can J Urol 2017 Apr;24(2):8693-8694

Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
April 2017

Editorial Comment.

J Urol 2017 03 16;197(3 Pt 1):601. Epub 2016 Dec 16.

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University/Thomas Jefferson University Hospital, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.09.151DOI Listing
March 2017

Prostate Cancer Statistics: Anything You Want Them To Be.

Can J Urol 2017 Feb;24(1):8603-8604

Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
February 2017

Fluorescence in situ hybridization (FISH) in the diagnosis of bladder and upper tract urothelial carcinoma: the largest single-institution experience to date.

Can J Urol 2017 Feb;24(1):8620-8626

Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
February 2017

Prostate, Breast and Ovarian Cancer Genetic Risk Assessment: Connecting the Dots.

Can J Urol 2016 Oct;23(5):8429

Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
October 2016

Big Data Equals Big Challenges for Prostate Cancer.

Can J Urol 2016 Aug;23(4):8329

Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
August 2016

Dosing, administration, and safety of radium-223: How I do it.

Can J Urol 2016 Jun;23(3):8301-5

Department of Radiation Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
June 2016

TV Drug Commercials: Keeping Physicians Informed.

Can J Urol 2016 Apr;23(2):8188

Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
April 2016

How I Do It: Genetic counseling and genetic testing for inherited prostate cancer.

Can J Urol 2016 Apr;23(2):8247-53

Division of Population Science, Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
April 2016

VPAC1 Targeted (64)Cu-TP3805 Positron Emission Tomography Imaging of Prostate Cancer: Preliminary Evaluation in Man.

Urology 2016 Feb 28;88:111-8. Epub 2015 Oct 28.

Department of Radiology, Thomas Jefferson University, Philadelphia, PA; Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00904295150099
Publisher Site
http://dx.doi.org/10.1016/j.urology.2015.10.012DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4788593PMC
February 2016

Punishing Physicians for PSA Screening.

Can J Urol 2015 Dec;22(6):8042

Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
December 2015

Robotic and Open Radical Prostatectomy: Celebrating Oncologic Equivalence.

Can J Urol 2015 Oct;22(5):7942-3

Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
October 2015

Survival Outcomes of Sipuleucel-T Phase III Studies: Impact of Control-Arm Cross-Over to Salvage Immunotherapy.

Cancer Immunol Res 2015 Sep 5;3(9):1063-9. Epub 2015 May 5.

Department of Urology, Jefferson Kimmel Cancer Center, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/2326-6066.CIR-15-0006DOI Listing
September 2015

Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer.

Am J Pathol 2015 Sep;185(9):2505-22

Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania; Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania; Prostate Cancer Discovery and Development Program, Wistar Institute, Philadelphia, Pennsylvania; Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2015.04.026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4597281PMC
September 2015

Structure-Based Screen Identifies a Potent Small Molecule Inhibitor of Stat5a/b with Therapeutic Potential for Prostate Cancer and Chronic Myeloid Leukemia.

Mol Cancer Ther 2015 Aug 29;14(8):1777-93. Epub 2015 May 29.

Department of Cancer Biology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. Department of Urology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. Department of Medical Oncology, Sidney Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-14-0883DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4547362PMC
August 2015

DNA-PKcs-Mediated Transcriptional Regulation Drives Prostate Cancer Progression and Metastasis.

Cancer Cell 2015 Jul;28(1):97-113

Department of Cancer Biology, Thomas Jefferson University, Philadelphia, PA 19107, USA; Department of Urology, Thomas Jefferson University, Philadelphia, PA 19107, USA; Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA; Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ccell.2015.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4531387PMC
July 2015

Risk factors for biochemical recurrence after robotic assisted radical prostatectomy: a single surgeon experience.

BMC Urol 2015 Apr 8;15:27. Epub 2015 Apr 8.

Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, 1025 Walnut St. Suite 1112, Philadelphia, PA, 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/s12894-015-0024-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4391671PMC
April 2015

The testosterone storm.

Can J Urol 2015 Apr;22(2):7677

Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
April 2015

Genomic classifier identifies men with adverse pathology after radical prostatectomy who benefit from adjuvant radiation therapy.

J Clin Oncol 2015 Mar 9;33(8):944-51. Epub 2015 Feb 9.

Robert B. Den, Edouard J. Trabulsi, Adam P. Dicker, Costas D. Lallas, and Leonard G. Gomella, Sidney Kimmel Medical College at Thomas Jefferson University, Philadelphia, PA; Firas Abdollah, Vattikuti Urology Institute, Henry Ford Hospital, Detroit; Felix Y. Feng, University of Michigan, Ann Arbor, MI; R. Jeffrey Karnes, Mayo Clinic, Rochester, MN; and Kasra Yousefi, Voleak Choeurng, and Elai Davicioni, GenomeDx Biosciences, Vancouver, British Columbia, Canada.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2015/02/03/JCO.2014.59
Web Search
http://www.pcf.org/atf/cf/%7B7c77d6a2-5859-4d60-af47-132fd0f
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.59.0026
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.59.0026DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4884273PMC
March 2015

Adjuvant versus salvage radiation therapy for prostate cancer patients with adverse pathologic features: comparative analysis of long-term outcomes.

Am J Clin Oncol 2015 Feb;38(1):55-60

*Department of Radiation Oncology †Robert Wood Johnson School of Osteopathic Medicine, University of Medicine & Dentistry of New Jersey, New Brunswick, NJ ‡Department of Pharmacology and Experimental Therapeutics, Division of Biostatistics §Department of Urology, Kimmel Cancer Center, Jefferson Medical College, Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/COC.0b013e318287bb6bDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6036623PMC
February 2015

Duration of androgen suppression before radiotherapy for localized prostate cancer: radiation therapy oncology group randomized clinical trial 9910.

J Clin Oncol 2015 Feb 22;33(4):332-9. Epub 2014 Dec 22.

Thomas M. Pisansky, Mayo Clinic, Rochester, MN; Daniel Hunt and James J. Dignam, Radiation Therapy Oncology Group Statistical Center; Leonard G. Gomella, Thomas Jefferson University, Philadelphia, PA; Mahul B. Amin and Howard M. Sandler, Cedars-Sinai Medical Center, Los Angeles; Daniel M. Chinn, John Muir Medical Center-Concord Campus, Concord; Seth A. Rosenthal, Sutter Medical Group, Sacramento, CA; Michael J. Seider, Akron City Hospital, Akron, OH; Elizabeth M. Gore, Zablocki Veterans Administration Medical Center-Wood, Milwaukee, WI; Marvin Z. Rotman, Brooklyn Minority-Based Community Clinical Oncology Program, State University of New York Downstate, Brooklyn, NY; William U. Shipley, Massachusetts General Hospital, Boston, MA; James J. Dignam, University of Chicago, Chicago, IL; Alexander G. Balogh, Tom Baker Cancer Centre, Calgary, Alberta; Marie Duclos, McGill University, Montreal, Quebec; Glenn S. Bauman, London Regional Cancer Program, London; and Himanshu R. Lukka, McMaster University, Hamilton, Ontario, Canada.

View Article

Download full-text PDF

Source
http://jco.ascopubs.org/content/early/2014/12/22/JCO.2014.58
Web Search
http://jco.ascopubs.org/cgi/doi/10.1200/JCO.2014.58.0662
Publisher Site
http://dx.doi.org/10.1200/JCO.2014.58.0662DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302214PMC
February 2015

Novel actions of next-generation taxanes benefit advanced stages of prostate cancer.

Clin Cancer Res 2015 Feb;21(4):795-807

Department of Cancer Biology, Thomas Jefferson University, Philadelphia, Pennsylvania. Department of Radiation Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania. Department of Medical Oncology, Thomas Jefferson University, Philadelphia, Pennsylvania. Department of Urology, Thomas Jefferson University, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-14-1358DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4333741PMC
February 2015

What's wrong with the practice of medicine today?

Can J Urol 2015 Feb;22(1):7589

Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
February 2015

Sortilin regulates progranulin action in castration-resistant prostate cancer cells.

Endocrinology 2015 Jan;156(1):58-70

Departments of Urology (R.T., A.Morc., M.T., S.-Q.X., M.S., K.G.L., D.H.B., L.G.G., A.Morr.), Biology of Prostate Cancer Program (L.G.G., A.Morr.), and Pathology, Anatomy, and Cell Biology (S.B., R.V.I.) and Cancer Cell Biology and Signaling Program (R.V.I.), Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107; Department of Health Sciences (A.Morc., M.S., A.B.), Endocrinology, University Magna Graecia of Catanzaro, 88100 Catanzaro, Italy; and CRS Development of Biomolecular Therapies (M.T., K.S.), Experimental Oncology Laboratory, Rizzoli Orthopedic Institute, 40136 Bologna, Italy.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1210/en.2014-1590DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272403PMC
January 2015

When 4 does not mean 4: a patient portal lesson.

Can J Urol 2014 Dec;21(6):7516

Thomas Jefferson University Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
December 2014

Prostate cancer and prostatocystitis: equal in the eyes of ICD-10.

Can J Urol 2014 Aug;21(4):7330-1

Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
August 2014

Safety of hexaminolevulinate for blue light cystoscopy in bladder cancer. A combined analysis of the trials used for registration and postmarketing data.

Urology 2014 Jul 24;84(1):122-6. Epub 2014 Apr 24.

Department of Urology, The University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2014.03.006DOI Listing
July 2014

Clinical Trials: naming confusion or YABA?

Can J Urol 2014 Jun;21(3):7255

Thomas Jefferson University, Philadelphia, PA.

View Article

Download full-text PDF

Source
June 2014

Recommendations for adjuvant post prostatectomy radiation.

Can J Urol 2014 Jun;21(3):7298

Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
June 2014

Prostate cancer: alcohol, cancer and 5α-reductase inhibitors-is there a link?

Nat Rev Urol 2014 May 29;11(5):253-4. Epub 2014 Apr 29.

Department of Urology, Kimmel Cancer Center, Thomas Jefferson University, 1025 Walnut Street, Suite 1112, Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2014.90DOI Listing
May 2014

Current management of advanced and castration resistant prostate cancer.

Can J Urol 2014 Apr;21(2 Supp 1):1-6

Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
April 2014

Practical guide to immunotherapy in castration resistant prostate cancer: the use of sipuleucel-T immunotherapy.

Can J Urol 2014 Apr;21(2 Supp 1):48-56

Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
April 2014

Prostate cancer genomics: understanding the new landscape.

Can J Urol 2014 Feb;21(1):7091

Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
February 2014

Transrectal prostate biopsy.

Urol Clin North Am 2013 Nov 11;40(4):457-72. Epub 2013 Sep 11.

Department of Urology, VA Medical Center, 1601 Kirkwood Highway, Wilmington, DE 19805, USA; Department of Urology, Thomas Jefferson University, 1025 Walnut Street, 1102, Philadelphia, PA 19107, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ucl.2013.07.012DOI Listing
November 2013

Pharmacologic inhibition of Jak2-Stat5 signaling By Jak2 inhibitor AZD1480 potently suppresses growth of both primary and castrate-resistant prostate cancer.

Clin Cancer Res 2013 Oct 13;19(20):5658-74. Epub 2013 Aug 13.

Authors' Affiliations: Departments of Cancer Biology, Urology, Pathology, and Medical Oncology, Kimmel Cancer Center; Department of Pharmacology and Experimental Therapeutics, Thomas Jefferson University, Philadelphia, Pennsylvania; and Oncology iMED, AstraZeneca R&D Boston, Waltham, Massachusetts.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0422DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6021137PMC
October 2013

Evolution of advanced technologies in prostate cancer radiotherapy.

Nat Rev Urol 2013 Oct 10;10(10):565-79. Epub 2013 Sep 10.

Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.

View Article

Download full-text PDF

Source
http://www.nature.com/articles/nrurol.2013.185
Publisher Site
http://dx.doi.org/10.1038/nrurol.2013.185DOI Listing
October 2013

Prostate cancer: a high value target for cost containment.

Can J Urol 2013 Oct;20(5):6888

Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
October 2013

Percutaneous cryoablation for recurrent low grade renal cell carcinoma after failed nephron-sparing surgery.

Can J Urol 2013 Oct;20(5):6933-7

Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

View Article

Download full-text PDF

Source
October 2013

Optimization of initial prostate biopsy in clinical practice: sampling, labeling and specimen processing.

J Urol 2013 Jun 26;189(6):2039-46. Epub 2013 Feb 26.

Division of Urologic Oncology, Department of Urology, New York University Langone Medical Center, New York, New York 10016, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2013.02.072DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3925148PMC
June 2013

Preventing and managing PSA recurrence following radical prostatectomy.

Can J Urol 2013 Jun;20(3):6755

View Article

Download full-text PDF

Source
June 2013

Introduction: the changing landscape of prostate cancer.

Semin Oncol 2013 Jun;40(3):241-3

Department of Radiation Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.04.017DOI Listing
June 2013

Retropubic, laparoscopic, or robotic radical prostatectomy: is there any real difference?

Semin Oncol 2013 Jun;40(3):286-96

Department of Urology, Kimmel Cancer Center, Thomas Jefferson University Philadelphia, PA, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2013.04.004DOI Listing
June 2013

Actos, slings, finasteride, and the vaccine compensation solution.

Can J Urol 2013 Apr;20(2):6668

View Article

Download full-text PDF

Source
April 2013